Duchenne Muscular Dystrophy Whole Blood

Duchenne Muscular Dystrophy (DMD) Whole Blood for Research

Duchenne muscular dystrophy is an X-linked genetic disorder caused by dystrophin gene mutations, leading to progressive muscle degeneration. Sanguine collects fresh whole blood from IRB-consented donors with a clinically confirmed DMD diagnosis for genomic, biomarker, and neuromuscular research.

Product Features

  • Fresh whole blood from clinically diagnosed DMD donors
  • Custom anticoagulants and collection tubes available
  • Same-day collection and shipment
  • Research Use Only (RUO)

De-identified Donor Data

  • Physician-confirmed DMD diagnosis, including genetic testing results where available
  • Demographics: age, sex assigned at birth, ethnicity
  • Relevant medical history and medication use

Applications

  • Dystrophin gene and exon-skipping research
  • Creatine kinase and muscle-damage biomarker studies
  • Gene expression and transcriptomic analysis
  • Drug response and gene-therapy mechanism studies

Also Available

DMD samples are also available as leukopak and PBMC for cell-based assays — contact us to discuss the right specimen type for your study.

Compliance and Quality

  • IRB-approved protocols and electronic informed consent
  • HIPAA-compliant donor data handling

Ordering and Customization

DMD whole blood is available in standard and custom volumes. Email learnmore@sanguinebio.com for international orders or documentation requirements. For the full specimen range, see our human whole blood collection.

Whole Blood

Frequently Asked Questions

Showing 1–12 of 26 results

Are samples IRB approved?

1 Answer

YES – All collections are conducted under IRB-approved protocols and electronic informed consent. Sanguine utilizes Advarra and WCG IRB for oversight.

YES – all our products are research use only (RUO).

Storage depends on sample type but often cryopreserved samples stored in liquid nitrogen can be stored for years.

Extensive customization is available. To discuss your project request a quote or email us at learnmore@sanguinebio.com.

Sanguine offers flexible prospective collection services tailored to fit your research. For more information and to request a quote, please see: our prospective biospecimen collection services page.

Timelines depend on condition, sample type, and I/E criteria but we often start collection within 2 weeks of signed agreement.

YES – we have in-stock inventory. You can also email us at learnmore@sanguinebio.com as we continually get new samples in our inventory.

Each sample from a different individual – Unique donor means each sample comes from a different person, ensuring biological diversity in your study.

YES – Unique donors can be specified and guaranteed based on your requirements.

For information about sample quality, please see: Quality and Compliance

YES – “IRB-approved collection protocols” and IRB approval documentation available upon request. Sanguine utilizes two internationally-recognized IRBs (Advarra and WCG IRB) for review and approval.

1
×

Ask a Question

Need a custom Whole Blood cohort?

Our scientific team can scope prospective collections with donor-specific I/E criteria, typically starting within 2 weeks of agreement.

More Information